Coherentmarketinsightsus

Bispecific Antibody (BsAb) is a synthetic protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two several types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and cancer of the colon are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies are emerging a technologically advanced solution for dual targeting strategies within same molecule. Increasing research and development for novel bispecific antibodies is one of the major factors driving the Global Bispecific Antibodies Market . A few of the major players operating in the bispecific antibodies treatment market includes AbbVie, Celgene, Ganymed Pharmaceuticals, Janssen Biotech, OncoMed Pharmaceuticals, Paktis Antibody Services GmbH, Fabion Pharmaceuticals among others. Although the marketplace is just...